top of page
Medvin icon
Medvin Clinical Research

Llame gratis :

1 (855) MEDVIN-1

  • Instagram
  • Facebook
  • LinkedIn
lupus.png

Lupus Trials (SLE)

We are conducting a clinical trial to evaluate the effectiveness and safety of innovative therapeutic interventions for individuals diagnosed with lupus, also known as systemic lupus erythematosus (SLE). Lupus is a chronic autoimmune disease that can affect multiple organs and systems in the body. This study aims to assess the potential of new treatments in managing lupus symptoms and improving patient outcomes.

participating criteria.png

Criterios de participación

  • Must be at least 18 years of age.

  • Must have a diagnosis of SLE. within the last 2 years

  • Must have ongoing disease activity despite medication use.

  • Must not have any other major medical condition.

locations.png

Criterios de participación

  • Apple Valley

  • Riverside

  • Menifee

  • Covina

  • Whittier

  • Tujunga

compensation.png

  • Earn up $1,900 participating ($100 per visit, 19 visits)

Criterios de participación

medications.png

  • FDA Approved Drug Benlysta (no placebo). All subjects will receive this FDA approved drug in different dosages

Criterios de participación

durations.png

  • 3 year study (19 visits)

Criterios de participación

Site Preference (Select up to 2)
Do you have a confirmed diagnosis of Systemic Lupus?
Do you have a history of any malignancy in the past 5 years?
Do you have a diagnosis of any other autoimmune diseases?
Have you previously been exposed to any biologics (Injections or Infusion medications)?

Trial Details

lupus.png

Lupus Trials (SLE)

We are conducting a clinical trial to evaluate the effectiveness and safety of innovative therapeutic interventions for individuals diagnosed with lupus, also known as systemic lupus erythematosus (SLE). Lupus is a chronic autoimmune disease that can affect multiple organs and systems in the body. This study aims to assess the potential of new treatments in managing lupus symptoms and improving patient outcomes.

lupus.png

Lupus Trials (SLE)

We are conducting a clinical trial to evaluate the effectiveness and safety of innovative therapeutic interventions for individuals diagnosed with lupus, also known as systemic lupus erythematosus (SLE). Lupus is a chronic autoimmune disease that can affect multiple organs and systems in the body. This study aims to assess the potential of new treatments in managing lupus symptoms and improving patient outcomes.

Site Preference (Select up to 2)
Do you have a confirmed diagnosis of Systemic Lupus?
Do you have a history of any malignancy in the past 5 years?
Do you have a diagnosis of any other autoimmune diseases?
Have you previously been exposed to any biologics (Injections or Infusion medications)?
participating criteria.png

Criterios de participación

  • Must be at least 18 years of age.

  • Must have a diagnosis of SLE. within the last 2 years

  • Must have ongoing disease activity despite medication use.

  • Must not have any other major medical condition.

locations.png

Criterios de participación

  • Apple Valley

  • Riverside

  • Menifee

  • Covina

  • Whittier

  • Tujunga

compensation.png

  • Earn up $1,900 participating ($100 per visit, 19 visits)

Criterios de participación

medications.png

  • FDA Approved Drug Benlysta (no placebo). All subjects will receive this FDA approved drug in different dosages

Criterios de participación

durations.png

  • 3 year study (19 visits)

Criterios de participación

Trial Details

Site Preference (Select up to 2)
Do you have a confirmed diagnosis of Systemic Lupus?
Do you have a history of any malignancy in the past 5 years?
Do you have a diagnosis of any other autoimmune diseases?
Have you previously been exposed to any biologics (Injections or Infusion medications)?
participating criteria.png

Criterios de participación

  • Must be at least 18 years of age.

  • Must have a diagnosis of SLE. within the last 2 years

  • Must have ongoing disease activity despite medication use.

  • Must not have any other major medical condition.

locations.png

Criterios de participación

  • Apple Valley

  • Riverside

  • Menifee

  • Covina

  • Whittier

  • Tujunga

compensation.png

  • Earn up $1,900 participating ($100 per visit, 19 visits)

Criterios de participación

medications.png

Criterios de participación

  • FDA Approved Drug Benlysta (no placebo). All subjects will receive this FDA approved drug in different dosages

durations.png

  • 3 year study (19 visits)

Criterios de participación

Trial Details

bottom of page